$3.12
-0.27-7.96%
At close: -
$3.19
0.072.24%
After Hours: 7:31 PM EDT
Comments
Loading...
InMed Pharmaceuticals (NASDAQ:INM) Stock, Earnings Estimates, EPS, And Revenue
InMed Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 12
EPS
$-3.640
Quarterly Revenue
$1.11M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$4.83M
Analyze the earnings history of InMed Pharmaceuticals using advanced sorting and filters.
Data brought to you by Benzinga APIs
InMed Pharmaceuticals (INM) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2022-09-23 | $-258.40 | $-5.50 | -4598.2 % |
| Q2 | 2022-02-14 | $-155.00 | $-5.75 | -2595.6 % |
InMed Pharmaceuticals (INM) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | 2024-02-13 | $1.24M | $1.39M | -10.8 % |
| Q4 | 2022-09-23 | $514.76K | $750.00K | -31.4 % |
| Q2 | 2022-02-14 | $265.09K | $120.00K | 120.9 % |
FAQ
When is InMed Pharmaceuticals (NASDAQ:INM) reporting earnings?
InMed Pharmaceuticals (INM) is scheduled to report earnings on May 13, 2025. The last reported earnings were for reported on February 12, 2025 for Q2.
What were the latest earnings per share (EPS) for InMed Pharmaceuticals (NASDAQ:INM)?
The Actual EPS was $-3.64, which missed the estimate of $0.00.
What were InMed Pharmaceuticals’s (NASDAQ:INM) revenues?
The Actual Revenue was $1.1M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.